Clinical trial
Phenserine on the Alzheimer's Treatment Horizon, Study 1
NCT06774261
Study timeline
Study start (actual)2025-02-01Date precision: day
Registry last updated2026-05-04
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Alzheimer Diseaseunresolved
Mild Cognitive Impairmentunresolved
Interventions
PhenserineDRUG
Sponsors & collaborators
Helse Stavanger HFlead sponsor
Helse Fonnacollaborator
St. Olavs Hospitalcollaborator
University Hospital of North Norwaycollaborator
University of Exetercollaborator
National Institutes of Health (NIH)collaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06774261 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.